Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Foodborne Pathog Dis ; 13(12): 695-699, 2016 12.
Article in English | MEDLINE | ID: mdl-27661133

ABSTRACT

BACKGROUND: Toxoplasmosis is caused by the protozoon Toxoplasma gondii, which is one of the most widespread parasites that infect animals and humans worldwide. One of the main routes of infection for humans is through the consumption of infected meat containing bradyzoites in tissue cysts. Pork is one of the foremost meat types associated with outbreaks of acute toxoplasmosis in humans. MATERIALS AND METHODS: Sixty blood samples were collected from finished pigs at slaughter and their sera was evaluated by an indirect-IgG ELISA. Matched muscle samples were obtained from the tongue and loin. Whole blood and tissue samples were evaluated to search for T. gondii DNA using a nested-polymerase chain reaction. RESULTS: Seroprevalence of T. gondii was 96.6% (58/60) of sampled pigs. Meanwhile, T. gondii DNA was present in 23.21% of tongue tissue samples (13/56), 7% of loin tissues (4/57), and 0% in blood samples (0/44), respectively. Two pigs were serologically indeterminate. CONCLUSION: This is the first report of the presence of T. gondii DNA in tissue samples obtained from finalized pigs. Results from the present study suggest a high exposure to T. gondii in pigs intended for human consumption from the tropical region of Mexico. Thus, the consumption of some undercooked pork meat meals typical from the southern region of Mexico could represent a significant risk for acquiring infection for the human population.


Subject(s)
Abdominal Muscles/parasitology , Food Contamination , Meat/parasitology , Swine Diseases/parasitology , Toxoplasma/growth & development , Toxoplasmosis, Animal/parasitology , Abattoirs , Abdominal Muscles/metabolism , Animals , Antibodies, Protozoan/analysis , DNA, Protozoan/metabolism , Enzyme-Linked Immunosorbent Assay , Food Inspection , Foodborne Diseases/epidemiology , Foodborne Diseases/etiology , Foodborne Diseases/parasitology , Humans , Immunoglobulin G/analysis , Meat/adverse effects , Meat/analysis , Mexico/epidemiology , Risk , Sus scrofa , Swine , Swine Diseases/blood , Swine Diseases/immunology , Swine Diseases/metabolism , Tongue/metabolism , Tongue/parasitology , Toxoplasma/immunology , Toxoplasma/isolation & purification , Toxoplasmosis/epidemiology , Toxoplasmosis/etiology , Toxoplasmosis/parasitology , Toxoplasmosis, Animal/blood , Toxoplasmosis, Animal/immunology , Toxoplasmosis, Animal/metabolism , Tropical Climate
2.
Afr J Tradit Complement Altern Med ; 8(5 Suppl): 164-9, 2011.
Article in English | MEDLINE | ID: mdl-22754070

ABSTRACT

Antitrypanosomal activity of chloroform extract of Senna villosa leaves was evaluated in the sub acute phase of mice infected with Trypanosoma cruzi. Oral doses of 3.3, 6.6 and 13.2 µg/g were tested during 15 days on infected mice BALB/c, beginning treatment 40 days after infection to evaluate specifically the antitrypanosomal activity over the amastigote form of the parasite. Two different amount of parasites (100 and 500) were inoculated to 25 mice for each doses tested. At the end of the assay the animals were sacrificed and cardiac and skeletal tissue sections were stained with hematoxylin-eosin (HE) for identification and quantification of amastigote nest. In mice infected with 100 parasites, a significant reduction in the number of amastigote nest was observed in cardiac tissue of treated animals at all doses evaluated (p<0.05). An important reduction of amastigote nest was also observed in treated animals and infected with 500 parasites in comparison with no treated mice or treated with allopurinol.


Subject(s)
Chagas Disease/drug therapy , Fabaceae/chemistry , Plant Extracts/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Animals , Chagas Disease/diagnosis , Chagas Disease/parasitology , Dose-Response Relationship, Drug , Drug Evaluation , Mice , Mice, Inbred BALB C , Plant Extracts/therapeutic use , Plant Leaves/chemistry , Trypanocidal Agents/isolation & purification , Trypanocidal Agents/therapeutic use , Trypanosoma cruzi/isolation & purification
3.
Afr J Tradit Complement Altern Med ; 8(5 Suppl): 198-207, 2011.
Article in English | MEDLINE | ID: mdl-22754075

ABSTRACT

The antiprotozoal activity in vivo against Trypanosoma cruzi of (8-hydroxymethylen)-trieicosanyl acetate was evaluated in BALB/c mice during the acute phase of Chagas' disease (15 days after infection). Animals were treated during 15 days at doses of 16.8 and 33.6 µg/g, reduced parasitemia of 77.6 and 64.1% was observed respectively, in comparison with positive control mice (allopurinol 8.5 µg/g) which reduced only 29.7%. Also, amastigote nests in cardiac tissue were significant reduced in treated mice groups. The regression of effect induced after the suppression of the treatment with the compound was evaluated; animals were infected and simultaneously began the treatment with the compound during 20 days (16.8 and 33.6 µg/g). Mice were monitored after the end of the treatment for one more week. A good antitrypanosomal response was observed (66.1 and 68.9% less than untreated mice) during treatment, but 8 days after suspension of treatment, parasitemia level increased, reducing only 58.6 and 56.29 % respectively in treated animals compared with no treated.


Subject(s)
Acetates/pharmacology , Chagas Disease/drug therapy , Eicosanoids/pharmacology , Fabaceae/chemistry , Plant Extracts/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Acetates/isolation & purification , Acetates/therapeutic use , Administration, Oral , Animals , Chagas Disease/parasitology , Dose-Response Relationship, Drug , Eicosanoids/isolation & purification , Eicosanoids/therapeutic use , Heart/parasitology , Mice , Mice, Inbred BALB C , Parasitemia/drug therapy , Plant Extracts/isolation & purification , Plant Extracts/therapeutic use , Trypanocidal Agents/isolation & purification , Trypanocidal Agents/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...